首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province Zambia
【2h】

Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province Zambia

机译:社区主导的消除对策(CoRE):一项社区随机对照试验的研究方案评估社区级反应性局灶性药物管理在降低赞比亚南部省份恶性疟原虫感染率和发病率方面的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundZambia is pushing for, and has made great strides towards, the elimination of malaria transmission in Southern Province. Reactive focal test and treat (RFTAT) using rapid diagnostic tests and artemether-lumefantrine (AL) has been key in making this progress. Reactive focal drug administration (RFDA) using dihydroartemisinin-piperaquine (DHAP), may be superior in accelerating clearance of the parasite reservoir in humans due to the provision of enhanced chemoprophylactic protection of at-risk populations against new infections. The primary aim of this study is to quantify the relative effectiveness of RFDA with DHAP against RFTAT with AL (standard of care) for reducing Plasmodium falciparum prevalence and incidence.
机译:背景赞比亚正在为消除南部省内的疟疾传播而努力,并已取得了很大进展。使用快速诊断测试和蒿甲醚-萤石碱(AL)的反应性局灶性测试和治疗(RFTAT)是取得这一进展的关键。使用双氢青蒿素-哌喹(DHAP)的反应性局灶性药物管理(RFDA)在加速人类体内寄生虫贮库的清除方面可能是优越的,因为它提供了高危人群针对新感染的化学预防保护。这项研究的主要目的是量化RFDA与DHAP相对于RFTAT与AL(护理标准)在降低恶性疟原虫患病率和发病率方面的相对有效性。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号